Helix Genetic Health Risk App for late-onset Alzheimer’s disease— 510(k) K192073

Substantially Equivalent

Helix Opco, LLC

FDA 510(k) clearance K192073 for Helix Genetic Health Risk App for late-onset Alzheimer’s disease, Substantially Equivalent on 2020-12-23. Applicant: Helix Opco, LLC.

Clearance details

Applicant
Helix Opco, LLC
Product code
Code PTA
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Toronto, CA
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.